Trial intelligence / Profile preview

Ciprofloxacin vs Cefepime in Febrile Neutropenic Patients

NCT00137787Phase 3Completed

Sponsor
Center for Supporting Hematology-Oncology Trials
Start
Apr 2005
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ciprofloxacin in febrile neutropenia (FN), sponsored by Center for Supporting Hematology-Oncology Trials. Started Apr 2005; status: completed.

02

Drugs

ciprofloxacin
03

Conditions

febrile neutropenia (FN)

Beyond the preview

Go deeper on NCT00137787.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00137787.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call